MeVis Medical Solutions AG (ETR:M3V)
Germany
· Delayed Price · Currency is EUR 23.40
0.00 (0.00%)
Apr 29, 2026, 5:35 PM CET
ETR:M3V Ratios and Metrics
Market cap in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | 2020 - 2016 |
| Market Capitalization | 43 | 45 | 42 | 52 | 62 | 59 | Upgrade
|
| Market Cap Growth | -7.87% | 7.83% | -19.01% | -16.96% | 4.91% | 2.52% | Upgrade
|
| Enterprise Value | 36 | 43 | 37 | 47 | 58 | 55 | Upgrade
|
| Last Close Price | 23.40 | 23.90 | 21.37 | 25.36 | 29.72 | 27.51 | Upgrade
|
| PE Ratio | 13.45 | 14.26 | 9.18 | 10.51 | 7.99 | 13.05 | Upgrade
|
| Forward PE | - | 16.98 | 16.98 | 16.98 | 16.98 | 16.98 | Upgrade
|
| PS Ratio | 2.65 | 2.81 | 2.47 | 2.98 | 3.32 | 3.66 | Upgrade
|
| PB Ratio | 2.39 | 2.53 | 2.35 | 2.90 | 3.49 | 3.33 | Upgrade
|
| P/TBV Ratio | 2.39 | 2.53 | 2.35 | 2.90 | 3.49 | 3.33 | Upgrade
|
| P/FCF Ratio | 11.39 | 12.07 | 14.72 | 8.95 | 13.18 | 6.53 | Upgrade
|
| P/OCF Ratio | 10.98 | 11.64 | 13.30 | 8.83 | 12.81 | 6.50 | Upgrade
|
| EV/Sales Ratio | 2.25 | 2.65 | 2.18 | 2.73 | 3.09 | 3.41 | Upgrade
|
| EV/EBITDA Ratio | 14.62 | 17.26 | 8.95 | 9.53 | 8.83 | 10.75 | Upgrade
|
| EV/EBIT Ratio | 15.55 | 18.35 | 9.24 | 9.72 | 8.96 | 11.02 | Upgrade
|
| EV/FCF Ratio | 9.65 | 11.39 | 13.00 | 8.19 | 12.26 | 6.09 | Upgrade
|
| Net Debt / Equity Ratio | -0.37 | -0.37 | -0.37 | -0.43 | -0.52 | -0.43 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.64 | -2.64 | -1.58 | -1.56 | -1.42 | -1.48 | Upgrade
|
| Net Debt / FCF Ratio | -1.74 | -1.74 | -2.29 | -1.34 | -1.97 | -0.84 | Upgrade
|
| Asset Turnover | 0.61 | 0.61 | 0.62 | 0.59 | 0.64 | 0.59 | Upgrade
|
| Quick Ratio | 4.13 | 4.13 | 4.14 | 3.99 | 4.68 | 4.41 | Upgrade
|
| Current Ratio | 4.24 | 4.24 | 4.26 | 4.10 | 4.78 | 4.56 | Upgrade
|
| Return on Equity (ROE) | 17.76% | 17.76% | 25.59% | 27.60% | 43.70% | 25.50% | Upgrade
|
| Return on Assets (ROA) | 5.54% | 5.54% | 9.17% | 10.26% | 13.76% | 11.33% | Upgrade
|
| Return on Invested Capital (ROIC) | 19.82% | 19.82% | 36.43% | 51.15% | 68.35% | 40.90% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.80% | 9.80% | 16.50% | 19.20% | 22.90% | 19.90% | Upgrade
|
| Earnings Yield | 7.43% | 7.01% | 10.90% | 9.52% | 12.51% | 7.66% | Upgrade
|
| FCF Yield | 8.78% | 8.28% | 6.79% | 11.17% | 7.59% | 15.30% | Upgrade
|
| Dividend Yield | 4.83% | 4.73% | 5.29% | 3.75% | - | - | Upgrade
|
| Total Shareholder Return | 4.83% | 4.73% | 5.29% | 3.75% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.